Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference newsletter

HIV Infection

Free Subscription 07.09.2020 10 AIDS 5 AIDS Res Hum Retroviruses 2 Antimicrob Agents Chemother 1 BMC Pediatr 5 Clin Infect Dis 1 Drugs 9 HIV Med 23 J Infect Dis 1 Lancet HIV 1 Nat Med 17 PLoS One 3 PLoS Pathog 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. GOTTERT A, McClair TL, Pulerwitz J, Friedland BA, et al
   What shapes resilience among people living with HIV? A multi-country analysis of data from the PLHIV Stigma Index 2.0.
   AIDS. 2020;34 Suppl 1:S19-S32.
   PubMed         Abstract available
   
   
2. FRIEDLAND BA, Gottert A, Hows J, Baral SD, et al
   The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide.
   AIDS. 2020;34 Suppl 1:S5-S18.
   PubMed         Abstract available
   
   
3. GEIBEL S, Gottert A, Friedland BA, Jeremiah K, et al
   Internalized stigma among people living with HIV: assessing the Internalized AIDS-Related Stigma Scale in four countries.
   AIDS. 2020;34 Suppl 1:S33-S42.
   PubMed         Abstract available
   
   
4. YAM EA, Pulerwitz J, Almonte D, Garcia F, et al
   Stigma among key populations living with HIV in the Dominican Republic: experiences of people of Haitian descent, MSM, and female sex workers.
   AIDS. 2020;34 Suppl 1:S43-S52.
   PubMed         Abstract available
   
   
5. BROADY TR, Brener L, Hopwood M, Cama E, et al
   HIV stigma by association among Australian gay and bisexual men.
   AIDS. 2020;34 Suppl 1:S53-S62.
   PubMed         Abstract available
   
   
6. LYONS CE, Olawore O, Turpin G, Coly K, et al
   Intersectional stigmas and HIV-related outcomes among a cohort of key populations enrolled in stigma mitigation interventions in Senegal.
   AIDS. 2020;34 Suppl 1:S63-S72.
   PubMed         Abstract available
   
   
7. YIGIT I, Modi RA, Weiser SD, Johnson MO, et al
   Effects of an intervention on internalized HIV-related stigma for individuals newly entering HIV care.
   AIDS. 2020;34 Suppl 1:S73-S82.
   PubMed         Abstract available
   
   
8. SINGH RJ, Sarna A, Schensul JJ, Mahapatra B, et al
   A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India.
   AIDS. 2020;34 Suppl 1:S83-S92.
   PubMed         Abstract available
   
   
9. NYBLADE L, Mbuya-Brown RJ, Ezekiel MJ, Addo NA, et al
   A total facility approach to reducing HIV stigma in health facilities: implementation process and lessons learned.
   AIDS. 2020;34 Suppl 1:S93-S102.
   PubMed         Abstract available
   
   
10. SIRAPRAPASIRI T, Srithanaviboonchai K, Chantcharas P, Suwanphatthana N, et al
    Integration and scale-up of efforts to measure and reduce HIV-related stigma: the experience of Thailand.
    AIDS. 2020;34 Suppl 1:S103-S114.
    PubMed         Abstract available
    
    

    
    AIDS Res Hum Retroviruses

11. CHOW D, Mau M, Hodis H, Kewcharoen J, et al
    CAROTID ARTERY PLAQUE BURDEN IN HIV IS ASSOCIATED WITH SOLUBLE MEDIATORS AND MONOCYTES.
    AIDS Res Hum Retroviruses. 2020 Aug 29. doi: 10.1089/AID.2020.0075.
    PubMed         Abstract available
    
    
12. MAMATKULOV A, Kazakova E, Ibadullaeva N, Joldasova E, et al
    Prevalence of antiretroviral drug resistance mutations among pre-treatment and ART-failured HIV patients in Uzbekistan.
    AIDS Res Hum Retroviruses. 2020 Sep 1. doi: 10.1089/AID.2020.0096.
    PubMed         Abstract available
    
    
13. LAN Y, He X, Xin R, Li L, et al
    Genetic characteristics of CRF12_BF first identified in Guangdong Province, China.
    AIDS Res Hum Retroviruses. 2020 Sep 1. doi: 10.1089/AID.2020.0193.
    PubMed         Abstract available
    
    
14. ZHANG Y, Luo Y, Li Y, Zhang YW, et al
    Genetic diversity, complicated recombination and deteriorating drug resistance among HIV-1 infected individuals in Wuhan, China.
    AIDS Res Hum Retroviruses. 2020 Sep 2. doi: 10.1089/AID.2020.0142.
    PubMed         Abstract available
    
    
15. RAM D, Kroll K, Reeves RK
    Skipped over - tuning NK cells towards HIV through alternative splicing.
    AIDS Res Hum Retroviruses. 2020 Aug 30. doi: 10.1089/AID.2020.0116.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

16. REICHMUTH ML, Homke R, Zurcher K, Sander P, et al
    Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-naive Patients.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00513.
    PubMed         Abstract available
    
    
17. VADDADY P, Kandala B, Yee KL
    Population Pharmacokinetic and Pharmacodynamic Analysis to Evaluate a Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in People Living with HIV-1.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00590.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

18. BUZIGI E, Pillay K, Siwela M
    Child acceptability of a novel provitamin A carotenoid, iron and zinc-rich complementary food blend prepared from pumpkin and common bean in Uganda: a randomised control trial.
    BMC Pediatr. 2020;20:412.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

19. BOULLE A, Davies MA, Hussey H, Ismail M, et al
    Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2020 Aug 29. pii: 5899044. doi: 10.1093/cid/ciaa1198.
    PubMed         Abstract available
    
    
20. JENKS JD, Prattes J, Frank J, Spiess B, et al
    Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay with Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: a Multicenter Cohort Study.
    Clin Infect Dis. 2020 Aug 31. pii: 5899800. doi: 10.1093/cid/ciaa1281.
    PubMed         Abstract available
    
    
21. KHALILI M, King WC, Kleiner DE, Jain MK, et al
    Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection.
    Clin Infect Dis. 2020 Sep 1. pii: 5900012. doi: 10.1093/cid/ciaa1303.
    PubMed         Abstract available
    
    
22. WORETA TA, Chalasani N
    Fatty Liver Disease in HIV-HBV Coinfection: A Cause for Concern.
    Clin Infect Dis. 2020 Sep 1. pii: 5900008. doi: 10.1093/cid/ciaa1300.
    PubMed        
    
    
23. MAURICE JB, Goldin R, Hall A, Price JC, et al
    Increased BMI and Type 2 diabetes are the main predictors of NAFLD and advanced fibrosis in liver biopsies of patients with HIV mono-infection.
    Clin Infect Dis. 2020 Sep 2. pii: 5900681. doi: 10.1093/cid/ciaa1302.
    PubMed         Abstract available
    
    

    
    Drugs

24. SCARSI KK, Havens JP, Podany AT, Avedissian SN, et al
    HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.
    Drugs. 2020 Aug 29. pii: 10.1007/s40265-020-01379.
    PubMed         Abstract available
    
    

    
    HIV Med

25. RYOM L, Cotter A, De Miguel R, Beguelin C, et al
    2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
    HIV Med. 2020 Sep 3. doi: 10.1111/hiv.12878.
    PubMed         Abstract available
    
    
26. D'ARMINIO MONFORTE A, Bonnet F, Bucher HC, Pourcher V, et al
    What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohorts.
    HIV Med. 2020;21 Suppl 2:3-16.
    PubMed         Abstract available
    
    
27. GHEIBI Z, Dianatinasab M, Haghparast A, Mirzazadeh A, et al
    Gender difference in all-cause mortality of people living with HIV in Iran: findings from a 20-year cohort study.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12940.
    PubMed         Abstract available
    
    
28. CICCULLO A, Borghetti A, Dusina A, Segala FV, et al
    The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12936.
    PubMed        
    
    
29. ANDRADE HB, da Silva I, Ramos GV, Medeiros DM, et al
    Short- and medium-term prognosis of HIV-infected patients receiving intensive care: a Brazilian multicentre prospective cohort study.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12939.
    PubMed         Abstract available
    
    
30. TABORELLI M, Suligoi B, Toffolutti F, Frova L, et al
    Excess liver-related mortality among people with AIDS compared to the general population: an Italian nationwide cohort study using multiple causes of death.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12937.
    PubMed         Abstract available
    
    
31. LEEME TB, Mine M, Lechiile K, Mulenga F, et al
    Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12951.
    PubMed         Abstract available
    
    
32. BOEKE CE, Khan S, Walsh F, Hettema A, et al
    Universal test and treat in relation to HIV disease progression: results from a stepped-wedge trial in Eswatini.
    HIV Med. 2020 Sep 2. doi: 10.1111/hiv.12941.
    PubMed         Abstract available
    
    
33. GIROMETTI N, Lander F, McOwan A, Nwokolo N, et al
    Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort.
    HIV Med. 2020 Sep 1. doi: 10.1111/hiv.12900.
    PubMed         Abstract available
    
    

    
    J Infect Dis

34. KRSAK M, Montague BT, Trowbridge P, Johnson SC, et al
    Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
35. JOHNSON WD, Rivadeneira N, Adegbite AH, Neumann MS, et al
    Human Immunodeficiency Virus Prevention for People Who Use Drugs: Overview of Reviews and the ICOS of PICOS.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
36. LEVITT A, Mermin J, Jones CM, See I, et al
    Infectious Diseases and Injection Drug Use: Public Health Burden and Response.
    J Infect Dis. 2020;222.
    PubMed        
    
    
37. CHAVIS NS, Klein PW, Cohen SM, Dempsey A, et al
    The Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program's Response to the Opioid Epidemic.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
38. RENO H, Fox B, Highfill C, McKee A, et al
    The Emerging Intersection Between Injection Drug Use and Early Syphilis in Nonurban Areas of Missouri, 2012-2018.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
39. PINANA JL, Xhaard A, Tridello G, Passweg J, et al
    Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation.
    J Infect Dis. 2020 Aug 29. pii: 5899001. doi: 10.1093.
    PubMed         Abstract available
    
    
40. WINETSKY D, Burack D, Antoniou P, Garcia B, et al
    Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
41. LYSS SB, Buchacz K, McClung RP, Asher A, et al
    Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs-United States, 2016-2019: Perspectives on Recent Experience and Lessons Learned.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
42. METCALFE R, Ragonnet-Cronin M, Bradley-Stewart A, McAuley A, et al
    From Hospital to the Community: Redesigning the Human Immunodeficiency Virus (HIV) Clinical Service Model to Respond to an Outbreak of HIV Among People Who Inject Drugs.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
43. SPRINGER SA, Barocas JA, Wurcel A, Nijhawan A, et al
    Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
44. JORDAN AE, Cleland CM, Wyka K, Schackman BR, et al
    Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
45. ROWAN SE, Kamis KF, Beum R, Bryan K, et al
    Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
46. GORBACH PM, Javanbakht M, Ragsdale A, Bolan RB, et al
    Methamphetamine Injection Among Young Men Who Have Sex With Men: Risk for Human Immunodeficiency Virus Transmission in a Los Angeles Cohort.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
47. JORDAN AE, Cleland CM, Schackman BR, Wyka K, et al
    Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
48. TUMPNEY M, John B, Panneer N, McClung RP, et al
    Human Immunodeficiency Virus (HIV) Outbreak Investigation Among Persons Who Inject Drugs in Massachusetts Enhanced by HIV Sequence Data.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
49. ASSOUMOU SA, Paniagua SM, Linas BP, Wang J, et al
    Rapid Versus Laboratory-Based Testing for HIV and Hepatitis C at a Drug Detoxification Treatment Center: A Randomized Trial.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
50. RAO S, Song W, Mulatu MS, Seena E, et al
    Human Immunodeficiency Virus Testing, Diagnosis, Linkage to Care, and Prevention Services Among Persons Who Inject Drugs, United States, 2012-2017.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
51. KREBS E, Zang X, Enns B, Min JE, et al
    Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
52. WESNER CA, Zhang W, Melstad S, Ruen E, et al
    Assessing County-Level Vulnerability for Opioid Overdose and Rapid Spread of Human Immunodeficiency Virus and Hepatitis C Infection in South Dakota.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
53. LEWIS R, Baugher AR, Finlayson T, Wejnert C, et al
    Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
54. KIM MM, Conyngham SC, Smith C, Higgins D, et al
    Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
55. ALLEN ST, Grieb SM, White RH, O'Rourke A, et al
    Human Immunodeficiency Virus Testing Among People Who Inject Drugs in Rural West Virginia.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    
56. ADAMS M, Sionean C, Broz D, Lewis R, et al
    Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use.
    J Infect Dis. 2020;222.
    PubMed         Abstract available
    
    

    
    Lancet HIV

57. RUTSTEIN SE, Smith DK, Dalal S, Baggaley RC, et al
    Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.
    Lancet HIV. 2020 Aug 27. pii: S2352-3018(20)30203.
    PubMed         Abstract available
    
    

    
    Nat Med

58. MALDINI CR, Claiborne DT, Okawa K, Chen T, et al
    Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo.
    Nat Med. 2020 Aug 31. pii: 10.1038/s41591-020-1039.
    PubMed         Abstract available
    
    

    
    PLoS One

59. CHOI YH, Zhang X, Srinivasamoorthy G, Purdy MA, et al
    Transcriptome analysis in rhesus macaques infected with hepatitis E virus genotype 1/3 infections and genotype 1 re-infection.
    PLoS One. 2020;15:e0237618.
    PubMed         Abstract available
    
    
60. ZHAO NQ, Vendrame E, Ferreira AM, Seiler C, et al
    Natural killer cell phenotype is altered in HIV-exposed seronegative women.
    PLoS One. 2020;15:e0238347.
    PubMed         Abstract available
    
    
61. TIAMIYU AB, Iliyasu G, Dayyab FM, Habib ZG, et al
    A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient's population in North Central Nigeria.
    PLoS One. 2020;15:e0238007.
    PubMed         Abstract available
    
    
62. SACKS-DAVIS R, Chibo D, Peach E, Aleksic E, et al
    Phylogenetic clustering networks among heterosexual migrants with new HIV diagnoses post-migration in Australia.
    PLoS One. 2020;15:e0237469.
    PubMed         Abstract available
    
    
63. KAUR S U, Oyeyemi BF, Shet A, Gopalan BP, et al
    Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy.
    PLoS One. 2020;15:e0238316.
    PubMed         Abstract available
    
    
64. CORREA A, Monteiro P, Calixto F, Batista JDL, et al
    Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV.
    PLoS One. 2020;15:e0238052.
    PubMed         Abstract available
    
    
65. FERNANDO R, McDowell AC, Bhavaraju R, Fraimow H, et al
    A model for bringing TB expertise to HIV providers: Medical consultations to the CDC-funded Regional Tuberculosis Training and Medical Consultation Centers, 2013-2017.
    PLoS One. 2020;15:e0236933.
    PubMed         Abstract available
    
    
66. MIKULSKA M, Nicolini LA, Signori A, Di Biagio A, et al
    Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
    PLoS One. 2020;15:e0237831.
    PubMed         Abstract available
    
    
67. SINDELAR K, Maponga C, Lekoala F, Mandara E, et al
    Beyond the facility: An evaluation of seven community-based pediatric HIV testing strategies and linkage to care outcomes in a high prevalence, resource-limited setting.
    PLoS One. 2020;15:e0236985.
    PubMed         Abstract available
    
    
68. PATTERSON B, Dinkele R, Gessner S, Morrow C, et al
    Sensitivity optimisation of tuberculosis bioaerosol sampling.
    PLoS One. 2020;15:e0238193.
    PubMed         Abstract available
    
    
69. CASCIO A, Colomba C, Di Carlo P, Serra N, et al
    Low bone mineral density in HIV-positive young Italians and migrants.
    PLoS One. 2020;15:e0237984.
    PubMed         Abstract available
    
    
70. ROBBINS SJ, Dauda W, Kokogho A, Ndembi N, et al
    Oral sex practices among men who have sex with men and transgender women at risk for and living with HIV in Nigeria.
    PLoS One. 2020;15:e0238745.
    PubMed         Abstract available
    
    
71. WULANDARI LPL, Guy R, Kaldor J
    The burden of HIV infection among men who purchase sex in low- and middle-income countries - a systematic review and meta-analysis.
    PLoS One. 2020;15:e0238639.
    PubMed         Abstract available
    
    
72. SOK S, Hong R, Chhoun P, Chann N, et al
    HIV risks and recent HIV testing among transgender women in Cambodia: Findings from a national survey.
    PLoS One. 2020;15:e0238314.
    PubMed         Abstract available
    
    
73. KAAYA S, Siril H, McAdam K, Ainebyona D, et al
    Agents of change: Comparing HIV-related risk behavior of people attending ART clinics in Dar es Salaam with members of their social networks.
    PLoS One. 2020;15:e0238240.
    PubMed         Abstract available
    
    
74. GUPTA S, Bromley J, Saffarian S
    High-speed imaging of ESCRT recruitment and dynamics during HIV virus like particle budding.
    PLoS One. 2020;15:e0237268.
    PubMed         Abstract available
    
    
75. LEECH AA, Christiansen CL, Linas BP, Jacobsen DM, et al
    Healthcare practitioner experiences and willingness to prescribe pre-exposure prophylaxis in the US.
    PLoS One. 2020;15:e0238375.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

76. MACHARIA GN, Yue L, Staller E, Dilernia D, et al
    Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.
    PLoS Pathog. 2020;16:e1008853.
    PubMed         Abstract available
    
    
77. SCHRIJVERS R, Rijck J, Demeulemeester J, Adachi N, et al
    Correction: LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs.
    PLoS Pathog. 2020;16:e1008894.
    PubMed         Abstract available
    
    
78. COTTRELL CA, van Schooten J, Bowman CA, Yuan M, et al
    Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates.
    PLoS Pathog. 2020;16:e1008753.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

79. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
    A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
    PubMed         Abstract available
    
    
80. HUANG D, Abbott RK, Havenar-Daughton C, Skog PD, et al
    B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
    Proc Natl Acad Sci U S A. 2020 Sep 1. pii: 2004489117.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: